Literature DB >> 858008

Cardiovascular effects of delta9-tetrahydrocannabinol in conscious and anaesthetized dogs.

E Friedman, S Gershon, B Hine, M Torrelio.   

Abstract

1. Temporal effects of delta9-tetrahydrocannabinol (THC) on heart rate and blood pressure in conscious dogs were compared to those in anaesthetized dogs. 2. In conscious dogs, THC in doses of 0.25 and 0.1 mg/kg resulted in maximal heart rate reductions of 48 and 41%, respectively, and in no significant change in blood pressure. 3. In anaesthetized animals THC in doses of 0.5 and 0.25 mg/kg caused a peak reduction in heart rate of 38 and 34%, and of blood pressure of 24 and 8%, respectively. 4. The results demonstrate that the bradycardia in response to THC in dogs is independent of the concomitant anaesthesia. 5. We conclude that the discrepancy between heart rate response to THC in dogs and in man is due to a species difference.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 858008      PMCID: PMC1667768          DOI: 10.1111/j.1476-5381.1977.tb07721.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.

Authors:  N L Benowitz; R T Jones
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

2.  A psycho-pharmacological study of some indole alkaloids.

Authors:  S GERSHON; W J LANG
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-01-01

3.  Studies on the bradycardia induced by (-)- -trans-tetrahydrocannabinol in anesthetized dogs.

Authors:  I Cavero; T Solomon; J P Buckley; B S Jandhyala
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

4.  Some cardiovascular effects of marihuana smoking in normal volunteers.

Authors:  S Johnson; E F Domino
Journal:  Clin Pharmacol Ther       Date:  1971 Sep-Oct       Impact factor: 6.875

5.  The effects of chronic administration of trans- 9 -tetrahydrocannabinol on behavior and the cardiovascular system of dogs.

Authors:  W L Dewey; J Jenkins; T O'Rourke; L S Harris
Journal:  Arch Int Pharmacodyn Ther       Date:  1972

6.  Certain observations on interrelationships between respiratory and cardiovascular effects of (-)- 9 -trans-tetrahydrocannabinol.

Authors:  I Cavero; R K Kubena; J Dziak; J P Buckley; B S Jandhyala
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05

7.  Pharmacology of some marijuana constituents and 2 heterocyclic analogues.

Authors:  W L Dewey; L S Harris; J F Howes; J S Kennedy; F E Granchelli; H G Pars; R K Razdan
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

8.  Comparison of tetrahydrocannabinol and synhexyl in man.

Authors:  L E Hollister; R K Richards; H K Gillespie
Journal:  Clin Pharmacol Ther       Date:  1968 Nov-Dec       Impact factor: 6.875

9.  Effects on humans of 9 -tetrahydrocannabinol administered by smoking.

Authors:  M Galanter; R J Wyatt; L Lemberger; H Weingartner; T B Vaughan; W T Roth
Journal:  Science       Date:  1972-05-26       Impact factor: 47.728

10.  Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.

Authors:  M Perez-Reyes; M C Timmons; M A Lipton; K H Davis; M E Wall
Journal:  Science       Date:  1972-08-18       Impact factor: 47.728

  10 in total
  1 in total

Review 1.  A review of the anesthetic implications of marijuana use.

Authors:  John C Alexander; Girish P Joshi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-05-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.